ATC Classification

A – Alimentary Tract and Metabolism
- A01 – Stomatological Preparations
  - A01A – Stomatological Preparations
- A02 – Drugs for Acid Related Disorders
  - A02A – Antacids
  - A02B – Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (GORD)
  - A02X – Other Drugs for Acid Related Disorders
- A03 – Drugs for Functional Gastrointestinal Disorders
  - A03A – Drugs for Functional Gastrointestinal Disorders
  - A03B – Belladonna and Derivatives, Plain
    - A03BA – Belladonna alkaloids, tertiary amines
    - A03BB – Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
  - A03C – Antispasmodics in Combination with Psycholeptics
  - A03D – Antispasmodics in Combination with Analgesics
  - A03E – Antispasmodics and Anticholinergics in Combination with Other Drugs
    - A03EA – Antispasmodics, psycholeptics and analgesics in combination
    - A03ED – Antispasmodics in combination with other drugs
  - A03F – Propulsives
    - A03FA – Propulsives
- A04 – Antiemetics and Antinauseants
  - A04A – Antiemetics and Antinauseants
    - A04AA – Serotonin (5HT3) antagonists
    - A04AD – Other antiemetics
- A05 – Bile and Liver Therapy
  - A05A – Bile Therapy
  - A05B – Liver Therapy, Lipotropics
    - A05BA – Liver therapy
  - A05C – Drugs for Bile Therapy and Lipotropics in Combination
- A06 – Drugs for Constipation
  - A06A – Drugs for Constipation
- A07 – Antidiarrheals, Intestinal Antiinflammatory/Antiinfective Agents
  - A07A – Intestinal Antiinfectives
  - A07B – Intestinal Adsorbents
  - A07C – Electrolytes with Carbohydrates
    - A07CA – Oral rehydration salt formulations
  - A07D – Antipropulsives
    - A07DA – Antipropulsives
  - A07E – Intestinal Antiinflammatory Agents
  - A07F – Antidiarrheal Microorganisms
    - A07FA – Antidiarrheal microorganisms
  - A07X – Other Antidiarrheals
    - A07XA – Other antidiarrheals
- A08 – Antiobesity Preparations, excl. Diet Products
  - A08A – Antiobesity Preparations, excl. Diet Products
- A09 – Digestives, incl. Enzymes
  - A09A – Digestives, incl. Enzymes
- A10 – Drugs Used in Diabetes
  - A10A – Insulins and Analogues
  - A10B – Blood Glucose Lowering Drugs, excl. Insulins
  - A10X – Other Drugs Used in Diabetes
    - A10XA – Aldose reductase inhibitors
- A11 – Vitamins
  - A11A – Multivitamins, Combinations
    - A11AA – Multivitamins with minerals
    - A11AB – Multivitamins, other combinations
  - A11B – Multivitamins, Plain
    - A11BA – Multivitamins, plain
  - A11C – Vitamin A and D, incl. Combinations of the Two
  - A11D – Vitamin B1, Plain and in Combination with Vitamin B6 and B12
    - A11DA – Vitamin B1, plain
    - A11DB – Vitamin B1 in combination with vitamin B6 and/or vitamin B12
  - A11E – Vitamin B-Complex, incl. Combinations
  - A11G – Ascorbic Acid (Vitamin C), incl. Combinations
    - A11GA – Ascorbic acid (vitamin C), plain
    - A11GB – Ascorbic acid (vitamin C), combinations
  - A11H – Other Plain Vitamin Preparations
    - A11HA – Other plain vitamin preparations
  - A11J – Other Vitamin Products, Combinations
- A12 – Mineral Supplements
  - A12A – Calcium
    - A12AA – Calcium
    - A12AX – Calcium, combinations with vitamin D and/or other drugs
  - A12B – Potassium
    - A12BA – Potassium
  - A12C – Other Mineral Supplements
- A13 – Tonics
  - A13A – Tonics
- A14 – Anabolic Agents for Systemic Use
  - A14A – Anabolic Steroids
    - A14AA – Androstan derivatives
    - A14AB – Estren derivatives
  - A14B – Other Anabolic Agents
- A15 – Appetite Stimulants
- A16 – Other Alimentary Tract and Metabolism Products
  - A16A – Other Alimentary Tract and Metabolism Products
B – Blood and Blood Forming Organs
- B01 – Antithrombotic Agents
  - B01A – Antithrombotic Agents
- B02 – Antihemorrhagics
  - B02A – Antifibrinolytics
    - B02AA – Amino acids
    - B02AB – Proteinase inhibitors
  - B02B – Vitamin K and Other Hemostatics
- B03 – Antianemic Preparations
  - B03A – Iron Preparations
  - B03B – Vitamin B12 and Folic Acid
    - B03BA – Vitamin B12 (cyanocobalamin and analogues)
    - B03BB – Folic acid and derivatives
  - B03X – Other Antianemic Preparations
    - B03XA – Other antianemic preparations
- B05 – Blood Substitutes and Perfusion Solutions
  - B05A – Blood and Related Products
    - B05AA – Blood substitutes and plasma protein fractions
    - B05AX – Other blood products
  - B05B – I.V. Solutions
  - B05C – Irrigating Solutions
  - B05D – Peritoneal Dialytics
    - B05DA – Isotonic solutions
    - B05DB – Hypertonic solutions
  - B05X – I.V. Solution Additives
  - B05Z – Hemodialytics and Hemofiltrates
    - B05ZA – Hemodialytics, concentrates
    - B05ZB – Hemofiltrates
- B06 – Other Hematological Agents
  - B06A – Other Hematological Agents
C – Cardiovascular System
- C01 – Cardiac Therapy
  - C01A – Cardiac Glycosides
  - C01B – Antiarrhythmics, Class I and III
  - C01C – Cardiac Stimulants excl. Cardiac Glycosides
  - C01D – Vasodilators Used in Cardiac Diseases
  - C01E – Other Cardiac Preparations
- C02 – Antihypertensives
  - C02A – Antiadrenergic Agents, Centrally Acting
  - C02B – Antiadrenergic Agents, Ganglion-Blocking
  - C02C – Antiadrenergic Agents, Peripherally Acting
    - C02CA – Alpha-adrenoreceptor antagonists
    - C02CC – Guanidine derivatives
  - C02D – Arteriolar Smooth Muscle, Agents Acting On
  - C02K – Other Antihypertensives
  - C02L – Antihypertensives and Diuretics in Combination
  - C02N – Combinations of Antihypertensives in ATC-GR. C02
- C03 – Diuretics
  - C03A – Low-Ceiling Diuretics, Thiazides
  - C03B – Low-Ceiling Diuretics, excl. Thiazides
  - C03C – High-Ceiling Diuretics
  - C03D – Aldosterone Antagonists and Other Potassium-Sparing Agents
    - C03DA – Aldosterone antagonists
    - C03DB – Other potassium-sparing agents
  - C03E – Diuretics and Potassium-Sparing Agents in Combination
    - C03EA – Low-ceiling diuretics and potassium-sparing agents
    - C03EB – High-ceiling diuretics and potassium-sparing agents
  - C03X – Other Diuretics
    - C03XA – Vasopressin antagonists
- C04 – Peripheral Vasodilators
  - C04A – Peripheral Vasodilators
- C05 – Vasoprotectives
  - C05A – Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
  - C05B – Antivaricose Therapy
  - C05C – Capillary Stabilizing Agents
    - C05CA – Bioflavonoids
    - C05CX – Other capillary stabilizing agents
- C07 – Beta Blocking Agents
  - C07A – Beta Blocking Agents
  - C07B – Beta Blocking Agents and Thiazides
  - C07C – Beta Blocking Agents and Other Diuretics
  - C07D – Beta Blocking Agents, Thiazides and Other Diuretics
    - C07DA – Beta blocking agents, non-selective, thiazides and other diuretics
    - C07DB – Beta blocking agents, selective, thiazides and other diuretics
  - C07E – Beta Blocking Agents and Vasodilators
    - C07EA – Beta blocking agents, non-selective, and vasodilators
    - C07EB – Beta blocking agents, selective, and vasodilators
  - C07F – Beta Blocking Agents, Other Combinations
    - C07FB – Beta blocking agents and calcium channel blockers
    - C07FX – Beta blocking agents, other combinations
- C08 – Calcium Channel Blockers
  - C08C – Selective Calcium Channel Blockers with mainly Vascular Effects
    - C08CA – Dihydropyridine derivatives
    - C08CX – Other selective calcium channel blockers with mainly vascular effects
  - C08D – Selective Calcium Channel Blockers with Direct Cardiac Effects
    - C08DA – Phenylalkylamine derivatives
    - C08DB – Benzothiazepine derivatives
  - C08E – Non-Selective Calcium Channel Blockers
    - C08EA – Phenylalkylamine derivatives
    - C08EX – Other non-selective calcium channel blockers
  - C08G – Calcium Channel Blockers and Diuretics
    - C08GA – Calcium channel blockers and diuretics
- C09 – Agents Acting on the Renin-Angiotensin System
  - C09A – ACE Inhibitors, Plain
    - C09AA – ACE inhibitors, plain
  - C09B – ACE Inhibitors, Combinations
  - C09C – Angiotensin II Receptor Blockers (ARBs), Plain
    - C09CA – Angiotensin II receptor blockers (ARBs), plain
  - C09D – Angiotensin II Receptor Blockers (ARBs), Combinations
  - C09X – Other Agents Acting on the Renin-Angiotensin System
    - C09XA – Renin-inhibitors
- C10 – Lipid Modifying Agents
  - C10A – Lipid Modifying Agents, Plain
  - C10B – Lipid Modifying Agents, Combinations
D – Dermatologicals
- D01 – Antifungals for Dermatological Use
  - D01A – Antifungals for Topical Use
  - D01B – Antifungals for Systemic Use
    - D01BA – Antifungals for systemic use
- D02 – Emollients and Protectives
  - D02A – Emollients and Protectives
  - D02B – Protectives Against UV-Radiation
    - D02BA – Protectives against UV-radiation for topical use
    - D02BB – Protectives against UV-radiation for systemic use
- D03 – Preparations for Treatment of Wounds and Ulcers
  - D03A – Cicatrizants
    - D03AA – Cod-liver oil ointments
    - D03AX – Other cicatrizants
  - D03B – Enzymes
    - D03BA – Proteolytic enzymes
- D04 – Antipruritics, incl. Antihistamines, Anesthetics, etc.
  - D04A – Antipruritics, incl. Antihistamines, Anesthetics, etc.
- D05 – Antipsoriatics
  - D05A – Antipsoriatics for Topical Use
  - D05B – Antipsoriatics for Systemic Use
- D06 – Antibiotics and Chemotherapeutics for Dermatological Use
  - D06A – Antibiotics for Topical Use
    - D06AA – Tetracycline and derivatives
    - D06AX – Other antibiotics for topical use
  - D06B – Chemotherapeutics for Topical Use
  - D06C – Antibiotics and Chemotherapeutics, Combinations
- D07 – Corticosteroids, Dermatological Preparations
  - D07A – Corticosteroids, Plain
  - D07B – Corticosteroids, Combinations with Antiseptics
  - D07C – Corticosteroids, Combinations with Antibiotics
  - D07X – Corticosteroids, Other Combinations
- D08 – Antiseptics and Disinfectants
  - D08A – Antiseptics and Disinfectants
- D09 – Medicated Dressings
  - D09A – Medicated Dressings
- D10 – Anti-Acne Preparations
  - D10A – Anti-Acne Preparations for Topical Use
  - D10B – Anti-Acne Preparations for Systemic Use
    - D10BA – Retinoids for treatment of acne
    - D10BX – Other anti-acne preparations for systemic use
- D11 – Other Dermatological Preparations
  - D11A – Other Dermatological Preparations
G – Genito Urinary System and Sex Hormones
- G01 – Gynecological Antiinfectives and Antiseptics
  - G01A – Antiinfectives and Antiseptics, excl. Combinations with Corticosteroids
  - G01B – Antiinfectives/Antiseptics in Combination with Corticosteroids
- G02 – Other Gynecologicals
  - G02A – Uterotonics
  - G02B – Contraceptives for Topical Use
    - G02BA – Intrauterine contraceptives
    - G02BB – Intravaginal contraceptives
  - G02C – Other Gynecologicals
- G03 – Sex Hormones and Modulators of The Genital System
  - G03A – Hormonal Contraceptives for Systemic Use
  - G03B – Androgens
    - G03BA – 3-oxoandrosten (4) derivatives
    - G03BB – 5-androstanon (3) derivatives
  - G03C – Estrogens
  - G03D – Progestogens
  - G03E – Androgens and Female Sex Hormones in Combination
  - G03F – Progestogens and Estrogens in Combination
    - G03FA – Progestogens and estrogens, fixed combinations
    - G03FB – Progestogens and estrogens, sequential preparations
  - G03G – Gonadotropins and Other Ovulation Stimulants
    - G03GA – Gonadotropins
    - G03GB – Ovulation stimulants, synthetic
  - G03H – Antiandrogens
    - G03HA – Antiandrogens, plain
    - G03HB – Antiandrogens and estrogens
  - G03X – Other Sex Hormones and Modulators of The Genital System
- G04 – Urologicals
  - G04B – Urologicals
  - G04C – Drugs Used in Benign Prostatic Hypertrophy
H – Systemic Hormonal Preparations, excl. Sex Hormones and Insulins
- H01 – Pituitary and Hypothalamic Hormones and Analogues
  - H01A – Anterior Pituitary Lobe Hormones and Analogues
  - H01B – Posterior Pituitary Lobe Hormones
    - H01BA – Vasopressin and analogues
    - H01BB – Oxytocin and analogues
  - H01C – Hypothalamic Hormones
- H02 – Corticosteroids for Systemic Use
  - H02A – Corticosteroids for Systemic Use, Plain
    - H02AA – Mineralocorticoids
    - H02AB – Glucocorticoids
  - H02B – Corticosteroids for Systemic Use, Combinations
    - H02BX – Corticosteroids for systemic use, combinations
  - H02C – Antiadrenal Preparations
    - H02CA – Anticorticosteroids
- H03 – Thyroid Therapy
  - H03A – Thyroid Preparations
    - H03AA – Thyroid hormones
  - H03B – Antithyroid Preparations
  - H03C – Iodine Therapy
    - H03CA – Iodine therapy
- H04 – Pancreatic Hormones
  - H04A – Glycogenolytic Hormones
    - H04AA – Glycogenolytic hormones
- H05 – Calcium Homeostasis
  - H05A – Parathyroid Hormones and Analogues
    - H05AA – Parathyroid hormones and analogues
  - H05B – Anti-Parathyroid Agents
    - H05BA – Calcitonin preparations
    - H05BX – Other anti-parathyroid agents
J – Antiinfectives for Systemic Use
- J01 – Antibacterials for Systemic Use
  - J01A – Tetracyclines
    - J01AA – Tetracyclines
  - J01B – Amphenicols
    - J01BA – Amphenicols
  - J01C – Beta-Lactam Antibacterials, Penicillins
  - J01D – Other Beta-Lactam Antibacterials
  - J01E – Sulfonamides and Trimethoprim
  - J01F – Macrolides, Lincosamides and Streptogramins
  - J01G – Aminoglycoside Antibacterials
    - J01GA – Streptomycins
    - J01GB – Other aminoglycosides
  - J01M – Quinolone Antibacterials
    - J01MA – Fluoroquinolones
    - J01MB – Other quinolones
  - J01R – Combinations of Antibacterials
    - J01RA – Combinations of antibacterials
  - J01X – Other Antibacterials
- J02 – Antimycotics for Systemic Use
  - J02A – Antimycotics for Systemic Use
- J04 – Antimycobacterials
  - J04A – Drugs for Treatment of Tuberculosis
  - J04B – Drugs for Treatment of Lepra
    - J04BA – Drugs for treatment of lepra
- J05 – Antivirals for Systemic Use
  - J05A – Direct Acting Antivirals
- J06 – Immune Sera and Immunoglobulins
  - J06A – Immune Sera
    - J06AA – Immune sera
  - J06B – Immunoglobulins
- J07 – Vaccines
  - J07A – Bacterial Vaccines
  - J07B – Viral Vaccines
  - J07C – Bacterial and Viral Vaccines, Combined
    - J07CA – Bacterial and viral vaccines, combined
  - J07X – Other Vaccines
L – Antineoplastic and Immunomodulating Agents
- L01 – Antineoplastic Agents
- L02 – Endocrine Therapy
  - L02A – Hormones and Related Agents
  - L02B – Hormone Antagonists and Related Agents
- L03 – Immunostimulants
  - L03A – Immunostimulants
- L04 – Immunosuppressants
  - L04A – Immunosuppressants
M – Musculo-Skeletal System
- M01 – Antiinflammatory and Antirheumatic Products
  - M01A – Antiinflammatory and Antirheumatic Products, Non-Steroids
  - M01B – Antiinflammatory/antirheumatic Agents in Combination
    - M01BA – Antiinflammatory/antirheumatic agents in combination with corticosteroids
    - M01BX – Other antiinflammatory/antirheumatic agents in combination with other drugs
  - M01C – Specific Antirheumatic Agents
- M02 – Topical Products for Joint and Muscular Pain
  - M02A – Topical Products for Joint and Muscular Pain
- M03 – Muscle Relaxants
  - M03A – Muscle Relaxants, Peripherally Acting Agents
  - M03B – Muscle Relaxants, Centrally Acting Agents
  - M03C – Muscle Relaxants, Directly Acting Agents
    - M03CA – Dantrolene and derivatives
- M04 – Antigout Preparations
  - M04A – Antigout Preparations
- M05 – Drugs for Treatment of Bone Diseases
  - M05B – Drugs Affecting Bone Structure and Mineralization
- M09 – Other Drugs for Disorders of The Musculo-Skeletal System
  - M09A – Other Drugs for Disorders of The Musculo-Skeletal System
N – Nervous System
- N01 – Anesthetics
  - N01A – Anesthetics, General
  - N01B – Anesthetics, Local
- N02 – Analgesics
  - N02A – Opioids
  - N02B – Other Analgesics and Antipyretics
  - N02C – Antimigraine Preparations
- N03 – Antiepileptics
  - N03A – Antiepileptics
- N04 – Anti-Parkinson Drugs
  - N04A – Anticholinergic Agents
  - N04B – Dopaminergic Agents
  - N04C – Other Antiparkinson Drugs
    - N04CX – Other antiparkinson drugs
- N05 – Psycholeptics
- N06 – Psychoanaleptics
  - N06A – Antidepressants
  - N06B – Psychostimulants, Agents Used for ADHD and Nootropics
  - N06C – Psycholeptics and Psychoanaleptics in Combination
    - N06CA – Antidepressants in combination with psycholeptics
    - N06CB – Psychostimulants in combination with psycholeptics
  - N06D – Anti-Dementia Drugs
    - N06DA – Anticholinesterases
    - N06DX – Other anti-dementia drugs
- N07 – Other Nervous System Drugs
  - N07A – Parasympathomimetics
  - N07B – Drugs Used in Addictive Disorders
  - N07C – Antivertigo Preparations
    - N07CA – Antivertigo preparations
  - N07X – Other Nervous System Drugs
    - N07XA – Gangliosides and ganglioside derivatives
    - N07XX – Other nervous system drugs
P – Antiparasitic Products, Insecticides and Repellents
- P01 – Antiprotozoals
  - P01A – Agents Against Amoebiasis and Other Protozoal Diseases
  - P01B – Antimalarials
  - P01C – Agents Against Leishmaniasis and Trypanosomiasis
- P02 – Anthelmintics
  - P02B – Antitrematodals
  - P02C – Antinematodal Agents
  - P02D – Anticestodals
    - P02DA – Salicylic acid derivatives
    - P02DX – Other anticestodals
- P03 – Ectoparasiticides, incl. Scabicides, Insecticides and Repellents
  - P03A – Ectoparasiticides, incl. Scabicides
  - P03B – Insecticides and Repellents
    - P03BA – Pyrethrines
    - P03BX – Other insecticides and repellents
R – Respiratory System
- R01 – Nasal Preparations
  - R01A – Decongestants and Other Nasal Preparations for Topical Use
  - R01B – Nasal Decongestants for Systemic Use
    - R01BA – Sympathomimetics
- R02 – Throat Preparations
  - R02A – Throat Preparations
- R03 – Drugs for Obstructive Airway Diseases
  - R03A – Adrenergics, Inhalants
  - R03B – Other Drugs for Obstructive Airway Diseases, Inhalants
  - R03C – Adrenergics for Systemic Use
  - R03D – Other Systemic Drugs for Obstructive Airway Diseases
- R05 – Cough and Cold Preparations
  - R05C – Expectorants, excl. Combinations with Cough Suppressants
    - R05CA – Expectorants
    - R05CB – Mucolytics
  - R05D – Cough Suppressants, excl. Combinations with Expectorants
    - R05DA – Opium alkaloids and derivatives
    - R05DB – Other cough suppressants
  - R05F – Cough Suppressants and Expectorants, Combinations
    - R05FA – Opium derivatives and expectorants
    - R05FB – Other cough suppressants and expectorants
  - R05X – Other Cold Preparations
- R06 – Antihistamines for Systemic Use
  - R06A – Antihistamines for Systemic Use
- R07 – Other Respiratory System Products
  - R07A – Other Respiratory System Products
S – Sensory Organs
- S01 – Ophthalmologicals
  - S01A – Antiinfectives
  - S01B – Antiinflammatory Agents
  - S01C – Antiinflammatory Agents and Antiinfectives in Combination
  - S01E – Antiglaucoma Preparations and Miotics
  - S01F – Mydriatics and Cycloplegics
    - S01FA – Anticholinergics
    - S01FB – Sympathomimetics excl. antiglaucoma preparations
  - S01G – Decongestants and Antiallergics
    - S01GA – Sympathomimetics used as decongestants
    - S01GX – Other antiallergics
  - S01H – Local Anesthetics
    - S01HA – Local anesthetics
  - S01J – Diagnostic Agents
    - S01JA – Colouring agents
    - S01JX – Other ophthalmological diagnostic agents
  - S01K – Surgical Aids
    - S01KA – Viscoelastic substances
    - S01KX – Other surgical aids
  - S01L – Ocular Vascular Disorder Agents
    - S01LA – Antineovascularisation agents
  - S01X – Other Ophthalmologicals
    - S01XA – Other ophthalmologicals
- S02 – Otologicals
  - S02A – Antiinfectives
    - S02AA – Antiinfectives
  - S02B – Corticosteroids
    - S02BA – Corticosteroids
  - S02C – Corticosteroids and Antiinfectives in Combination
    - S02CA – Corticosteroids and antiinfectives in combination
  - S02D – Other Otologicals
    - S02DA – Analgesics and anesthetics
    - S02DC – Indifferent preparations
- S03 – Ophthalmological and Otological Preparations
  - S03A – Antiinfectives
    - S03AA – Antiinfectives
  - S03B – Corticosteroids
    - S03BA – Corticosteroids
  - S03C – Corticosteroids and Antiinfectives in Combination
    - S03CA – Corticosteroids and antiinfectives in combination
  - S03D – Other Ophthalmological and Otological Preparations
V – Various
- V01 – Allergens
  - V01A – Allergens
    - V01AA – Allergen extracts
- V03 – All Other Therapeutic Products
  - V03A – All Other Therapeutic Products
- V04 – Diagnostic Agents
  - V04B – Urine Tests
  - V04C – Other Diagnostic Agents
- V06 – General Nutrients
  - V06A – Diet Formulations for Treatment of Obesity
    - V06AA – Low-energy diets
  - V06B – Protein Supplements
  - V06C – Infant Formulas
    - V06CA – Nutrients without phenylalanine
  - V06D – Other Nutrients
- V07 – All Other Non-Therapeutic Products
  - V07A – All Other Non-Therapeutic Products
- V08 – Contrast Media
  - V08A – X-Ray Contrast Media, Iodinated
  - V08B – X-Ray Contrast Media, Non-Iodinated
    - V08BA – Barium sulfate containing X-ray contrast media
  - V08C – Magnetic Resonance Imaging Contrast Media
  - V08D – Ultrasound Contrast Media
    - V08DA – Ultrasound contrast media
- V09 – Diagnostic Radiopharmaceuticals
  - V09A – Central Nervous System
  - V09B – Skeleton
  - V09C – Renal System
  - V09D – Hepatic and Reticulo Endothelial System
  - V09E – Respiratory System
  - V09F – Thyroid
  - V09G – Cardiovascular System
  - V09H – Inflammation and Infection Detection
  - V09I – Tumour Detection
  - V09X – Other Diagnostic Radiopharmaceuticals
- V10 – Therapeutic Radiopharmaceuticals
  - V10A – Antiinflammatory Agents
  - V10B – Pain Palliation (Bone Seeking Agents)
  - V10X – Other Therapeutic Radiopharmaceuticals
- V20 – Surgical Dressings